vs

Side-by-side financial comparison of AGILYSYS INC (AGYS) and CASTLE BIOSCIENCES INC (CSTL). Click either name above to swap in a different company.

CASTLE BIOSCIENCES INC is the larger business by last-quarter revenue ($83.7M vs $80.4M, roughly 1.0× AGILYSYS INC). AGILYSYS INC runs the higher net margin — 12.3% vs -17.4%, a 29.7% gap on every dollar of revenue. On growth, AGILYSYS INC posted the faster year-over-year revenue change (15.6% vs -4.9%).

Agilysys Inc. is an American software company that develops and markets proprietary enterprise software and other products for the hospitality industry. The company specializes in point of sale, property management, inventory and procurement, document management, workforce management, and mobile and wireless products.

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

AGYS vs CSTL — Head-to-Head

Bigger by revenue
CSTL
CSTL
1.0× larger
CSTL
$83.7M
$80.4M
AGYS
Growing faster (revenue YoY)
AGYS
AGYS
+20.5% gap
AGYS
15.6%
-4.9%
CSTL
Higher net margin
AGYS
AGYS
29.7% more per $
AGYS
12.3%
-17.4%
CSTL

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
AGYS
AGYS
CSTL
CSTL
Revenue
$80.4M
$83.7M
Net Profit
$9.9M
$-14.5M
Gross Margin
62.5%
Operating Margin
14.6%
Net Margin
12.3%
-17.4%
Revenue YoY
15.6%
-4.9%
Net Profit YoY
158.4%
43.8%
EPS (diluted)
$0.35
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGYS
AGYS
CSTL
CSTL
Q1 26
$83.7M
Q4 25
$80.4M
$87.0M
Q3 25
$79.3M
$83.0M
Q2 25
$76.7M
$86.2M
Q1 25
$88.0M
Q4 24
$86.3M
Q3 24
$85.8M
Q2 24
$87.0M
Net Profit
AGYS
AGYS
CSTL
CSTL
Q1 26
$-14.5M
Q4 25
$9.9M
Q3 25
$11.7M
$-501.0K
Q2 25
$4.9M
$4.5M
Q1 25
$-25.8M
Q4 24
Q3 24
$2.3M
Q2 24
$8.9M
Gross Margin
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
62.5%
79.0%
Q3 25
61.7%
77.5%
Q2 25
61.7%
79.5%
Q1 25
81.4%
Q4 24
81.3%
Q3 24
81.8%
Q2 24
83.3%
Operating Margin
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
14.6%
-4.4%
Q3 25
17.8%
-8.2%
Q2 25
5.9%
-4.9%
Q1 25
-31.7%
Q4 24
4.7%
Q3 24
5.9%
Q2 24
5.8%
Net Margin
AGYS
AGYS
CSTL
CSTL
Q1 26
-17.4%
Q4 25
12.3%
Q3 25
14.8%
-0.6%
Q2 25
6.4%
5.2%
Q1 25
-29.4%
Q4 24
Q3 24
2.6%
Q2 24
10.3%
EPS (diluted)
AGYS
AGYS
CSTL
CSTL
Q1 26
$-0.49
Q4 25
$0.35
$-0.06
Q3 25
$0.41
$-0.02
Q2 25
$0.17
$0.15
Q1 25
$-0.90
Q4 24
$0.32
Q3 24
$0.08
Q2 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGYS
AGYS
CSTL
CSTL
Cash + ST InvestmentsLiquidity on hand
$81.5M
$63.8M
Total DebtLower is stronger
$10.1M
Stockholders' EquityBook value
$313.1M
$461.4M
Total Assets
$475.2M
$547.8M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGYS
AGYS
CSTL
CSTL
Q1 26
$63.8M
Q4 25
$81.5M
$299.5M
Q3 25
$59.3M
$287.5M
Q2 25
$55.6M
$275.9M
Q1 25
$275.2M
Q4 24
$293.1M
Q3 24
$95.0M
Q2 24
$85.6M
Total Debt
AGYS
AGYS
CSTL
CSTL
Q1 26
$10.1M
Q4 25
$10.1M
Q3 25
$10.0M
Q2 25
$10.0M
Q1 25
$10.0M
Q4 24
$10.0M
Q3 24
$10.0M
Q2 24
$10.0M
Stockholders' Equity
AGYS
AGYS
CSTL
CSTL
Q1 26
$461.4M
Q4 25
$313.1M
$470.9M
Q3 25
$296.7M
$467.0M
Q2 25
$283.2M
$455.4M
Q1 25
$440.3M
Q4 24
$455.8M
Q3 24
$441.1M
Q2 24
$423.9M
Total Assets
AGYS
AGYS
CSTL
CSTL
Q1 26
$547.8M
Q4 25
$475.2M
$578.6M
Q3 25
$425.6M
$562.8M
Q2 25
$426.0M
$544.7M
Q1 25
$501.7M
Q4 24
$531.2M
Q3 24
$514.6M
Q2 24
$487.3M
Debt / Equity
AGYS
AGYS
CSTL
CSTL
Q1 26
0.02×
Q4 25
0.02×
Q3 25
0.02×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGYS
AGYS
CSTL
CSTL
Operating Cash FlowLast quarter
$23.3M
$-22.1M
Free Cash FlowOCF − Capex
$22.7M
FCF MarginFCF / Revenue
28.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
2.35×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGYS
AGYS
CSTL
CSTL
Q1 26
$-22.1M
Q4 25
$23.3M
$26.9M
Q3 25
$15.2M
$22.6M
Q2 25
$-4.3M
$20.8M
Q1 25
$-6.0M
Q4 24
$24.4M
Q3 24
$23.3M
Q2 24
$24.0M
Free Cash Flow
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
$22.7M
$19.7M
Q3 25
$15.0M
$7.8M
Q2 25
$-5.0M
$11.6M
Q1 25
$-10.8M
Q4 24
$16.8M
Q3 24
$17.0M
Q2 24
$18.8M
FCF Margin
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
28.3%
22.7%
Q3 25
18.9%
9.4%
Q2 25
-6.5%
13.4%
Q1 25
-12.2%
Q4 24
19.5%
Q3 24
19.8%
Q2 24
21.6%
Capex Intensity
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
0.7%
8.3%
Q3 25
0.3%
17.9%
Q2 25
0.8%
10.7%
Q1 25
5.4%
Q4 24
8.8%
Q3 24
7.4%
Q2 24
6.0%
Cash Conversion
AGYS
AGYS
CSTL
CSTL
Q1 26
Q4 25
2.35×
Q3 25
1.30×
Q2 25
-0.89×
4.60×
Q1 25
Q4 24
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGYS
AGYS

Subscription And Maintenance$52.0M65%
Professional Services$17.7M22%
Products$10.7M13%

CSTL
CSTL

Segment breakdown not available.

Related Comparisons